ReviewCurrent neuropharmacology2021

Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A "Dimmer-Switch" Hypothesis.

Santiago J Ballaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.